MLchartDataset catalogue

Human-derived Enterococcus strain MNC-168

Term · Oncology and biomedicine · MLC-T-ONC-014254

An enteric-coated capsule formulation composed of a live Enterococcus strain derived from the human gut microbiome, with potential immunostimulating and antineoplastic activities. Upon administration of the human-derived Enterococcus strain MNC-168, the bacteria may activate the immune system through various mechanisms, including, but not limited to, the recruitment of tumor-infiltrating lymphocytes (TILs) and cytotoxic CD4+ and CD8+ T cells in the tumor microenvironment (TME). This may enhance anti-tumor immune responses and may eradicate tumor cells.

Table 1. Record
IdentifierMLC-T-ONC-014254
FieldOncology and biomedicine
Synonymslive bacterium MNC-168; human-derived live biotherapeutic product MNC-168
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-014254",
  "term": "Human-derived Enterococcus strain MNC-168",
  "field": "Oncology and biomedicine",
  "definition": "An enteric-coated capsule formulation composed of a live Enterococcus strain derived from the human gut microbiome, with potential immunostimulating and antineoplastic activities. Upon administration of the human-derived Enterococcus strain MNC-168, the bacteria may activate the immune system through various mechanisms, including, but not limited to, the recruitment of tumor-infiltrating lymphocytes (TILs) and cytotoxic CD4+ and CD8+ T cells in the tumor microenvironment (TME). This may enhance anti-tumor immune responses and may eradicate tumor cells.",
  "synonyms": [
    "live bacterium MNC-168",
    "human-derived live biotherapeutic product MNC-168"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/human-derived-enterococcus-strain-mnc-168/"
}

Record 8,767 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.